MAX Chat
Company Analysis Coloplast A/S
1. Summary
Advantages
- Price (98.58 $) is less than fair price (106.64 $)
- Dividends (2.66%) are higher than the sector average (1.67%).
- The stock's return over the last year (-9.65%) is higher than the sector average (-31.57%).
- The company's current efficiency (ROE=28.67%) is higher than the sector average (ROE=14.34%)
Disadvantages
- Current debt level 47.07% has increased over 5 years from 1.38%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Coloplast A/S | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -37.1% | 0.8% |
| 90 days | 5.7% | -35.6% | 11% |
| 1 year | -9.7% | -31.6% | 16.1% |
CLPBF vs Sector: Coloplast A/S has outperformed the "Healthcare" sector by 21.92% over the past year.
CLPBF vs Market: Coloplast A/S has significantly underperformed the market by -25.71% over the past year.
Stable price: CLPBF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CLPBF with weekly volatility of -0.1856% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (98.58 $) is lower than the fair price (106.64 $).
Price not significantly lower than the fair price: The current price (98.58 $) is slightly lower than the fair price by 8.2%.
4.2. P/E
P/E vs Sector: The company's P/E (38.7) is lower than that of the sector as a whole (46.01).
P/E vs Market: The company's P/E (38.7) is lower than that of the market as a whole (45.94).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (10.9) is higher than that of the sector as a whole (5.27).
P/BV vs Market: The company's P/BV (10.9) is higher than that of the market as a whole (4.35).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.23) is higher than that of the sector as a whole (4.28).
P/S vs Market: The company's P/S indicator (7.23) is lower than that of the market as a whole (12.92).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (25.63) is higher than that of the sector as a whole (17.25).
EV/Ebitda vs Market: The company's EV/Ebitda (25.63) is lower than that of the market as a whole (27.36).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.07% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.07%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.52%).
5.4. ROE
ROE vs Sector: The company's ROE (28.67%) is higher than that of the sector as a whole (14.34%).
ROE vs Market: The company's ROE (28.67%) is lower than that of the market as a whole (51.79%).
5.5. ROA
ROA vs Sector: The company's ROA (10.5%) is higher than that of the sector as a whole (7.38%).
ROA vs Market: The company's ROA (10.5%) is lower than that of the market as a whole (36.08%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.12%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.95%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.66% is higher than the average for the sector '1.67%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.66% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 2.66% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (93.43%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
